RSS

Genticel

All of the 39 investigation sites across seven European countries (Belgium, Finland, France, Germany, the Netherlands, Spain and the UK) are fully operational. Read more

These patents consolidate Genticel’s product pipeline in important emerging and mature pharmaceutical markets. Read more